NHS overcharged by millions for key drug, says watchdog
Drug company Concordia overcharged the NHS by millions for a key thyroid treatment, the Competition and Markets Authority has provisionally found. The CMA said that last year the NHS spent £34m on its drug, liothyronine, up from about £600,000 in 2006.The amount the